Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity

Proteomics

Volumn 12, Issue 4-5, 2012, Pages 607-620

  Peinado, Juan R ^a   Pardo, María ^b,c   De la Rosa, Olga ^d   Malagón, Maria M ^c,e  

^a Faculty of Medicine   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d Cellerix SA   (Spain)

^e UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Adipose tissue depots; Adipose tissue proteomics; Cell biology; Mature adipocytes; Secretome; Stromal vascular fraction

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTOKERATIN; FAT DROPLET; GLUCOSE; HEAT SHOCK PROTEIN 27; INSULIN; INTERLEUKIN 6; LIPID; RESISTIN; RETINOIC ACID; RETINOL; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; VIMENTIN;

ABDOMINAL FAT; ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; AUTOCRINE EFFECT; BROWN ADIPOSE TISSUE; CELL COMPONENT; CELL DIFFERENTIATION; CELL PROLIFERATION; COLD EXPOSURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOPLASMIC RETICULUM STRESS; FUNCTIONAL PROTEOMICS; GLUCOSE METABOLISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; MESOTHELIUM; NEUROLOGIC DISEASE; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; SUBCUTANEOUS FAT; THERMOGENESIS; VASCULITIS; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; CELL COMMUNICATION; HUMANS; OBESITY; PROTEOMICS;

EID: 84859250238     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100355     Document Type: Review

References (138)

1. Zhang, Y., Proenca, R., Maffei, M., Barone, M. et al., Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372, 425-432.
2. Maffei, M., Fei, H., Lee, G. H., Dani, C. et al., Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc. Natl. Acad. Sci. USA 1995, 92, 6957-6960.
3. Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L. et al., Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269, 543-546.
4. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, H. F., A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270, 26746-26749.
5. Lara-Castro, C., Fu, Y., Chung, B. H., Garvey, W. T., Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr. Opin. Lipidol. 2007, 18, 263-270.
6. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J. et al., The hormone resistin links obesity to diabetes. Nature 2001, 409, 307-312.
7. Deng, Y., Scherer, P. E., Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. NY Acad. Sci. 2010, 1212, E1-E19.
8. Chen, X., Hess, S., Adipose proteome analysis: Focus on mediators of insulin resistance. Exp. Rev. Proteomics 2008, 5, 827-839.
9. Ouchi, N., Parker, J. L., Lugus, J. J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97.
10. Mangge, H., Almer, G., Truschnig-Wilders, M., Schmidt, A. et al., Inflammation, adiponectin, obesity and cardiovascular risk. Curr. Med. Chem. 2010, 17, 4511-4520.
11. Poulos, S. P., Hausman, D. B., Hausman, G. J., The development and endocrine functions of adipose tissue. Mol. Cell. Endocrinol. 2010, 323, 20-34.
12. Vohl, M. C., Sladek, R., Robitaille, J., Gurd, S. et al., A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes. Res. 2004, 12, 1217-1222.
13. Chatterjee, R., Bhattacharya, P., Gavrilova, O., Glass, K. et al., Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy. J. Mol. Endocrinol. 2011, 46, 175-192.
14. Lanne, B., Potthast, F., Hoglund, A., Brockenhuus von Lowenhielm, H. et al., Thiourea enhances mapping of the proteome from murine white adipose tissue. Proteomics 2001, 1, 819-828.
15. Sanchez, J. C., Chiappe, D., Converset, V., Hoogland, C. et al., The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics 2001, 1, 136-163.
16. Corton, M., Villuendas, G., Botella, J. I., San Millan, J. L. et al., Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide. Proteomics 2004, 4, 438-441.
17. Wajchenberg, B. L., Giannella-Neto, D., da Silva, M. E., Santos, R. F., Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm. Metab. Res. 2002, 34, 616-621.
18. Samaras, K., Botelho, N. K., Chisholm, D. J., Lord, R. V., Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring) 2010, 18, 884-889.
19. Salgado-Somoza, A., Teijeira-Fernandez, E., Fernandez, A. L., Gonzalez-Juanatey, J. R., Eiras, S., Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H202-H209.
20. Roca-Rivada, A., Alonso, J., Al-Massadi, O., Castelao, C. et al., Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. J. Proteomics 2011, 74, 1068-1079.
21. Celis, J. E., Moreira, J. M., Cabezon, T., Gromov, P. et al., Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: Toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 2005, 4, 492-522.
22. Rajesh, R. V., Heo, G. N., Park, M. R., Nam, J. S. et al., Proteomic analysis of bovine omental, subcutaneous and intramuscular preadipocytes during in vitro adipogenic differentiation. Comp. Biochem. Physiol. Part D Genomics Proteomics 2010, 5, 234-244.
23. Koppen, A., Kalkhoven, E., Brown vs white adipocytes: The PPARgamma coregulator story. FEBS Lett. 2010, 584, 3250-3259.
24. Nedergaard, J., Bengtsson, T., Cannon, B., Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E444-E452.
25. Nedergaard, J., Bengtsson, T., Cannon, B., New powers of brown fat: fighting the metabolic syndrome. Cell Metab. 2011, 13, 238-240.
26. Kershaw, E. E., Flier, J. S., Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548-2556.
27. Despres, J. P., Lemieux, I., Bergeron, J., Pibarot, P. et al., Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1039-1049.
28. Fain, J. N., Cheema, P. S., Bahouth, S. W., Lloyd Hiler, M., Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 2003, 300, 674-678.
29. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., Bahouth, S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145, 2273-2282.
30. Cui, J., Panse, S., Falkner, B., The role of adiponectin in metabolic and vascular disease: a review. Clin. Nephrol. 2011, 75, 26-33.
31. Sam, S., Haffner, S., Davidson, M. H., D'Agostino R. B. Sr., et al., Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 2009, 32, 932-937.
32. O'Rourke, R. W., Metcalf, M. D., White, A. E., Madala, A. et al., Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. (London) 2009, 33, 978-990.
33. Kishida, K., Funahashi, T., Matsuzawa, Y., Visceral adiposity as a target for the management of the metabolic syndrome. Ann. Med. 2011, doi: 10.3109/07853890.2011.564202.
34. Rytka, J. M., Wueest, S., Schoenle, E. J., Konrad, D., The portal theory supported by venous drainage-selective fat transplantation. Diabetes 2011, 60, 56-63.
35. Duvnjak, L., Duvnjak, M., The metabolic syndrome - an ongoing story. J. Physiol. Pharmacol. 2009, 60, 19-24.
36. Virtue, S., Vidal-Puig, A., Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim. Biophys. Acta 2010, 1801, 338-349.
37. Araujo-Vilar, D., Lattanzi, G., Gonzalez-Mendez, B., Costa-Freitas, A. T. et al., Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J. Med. Genet. 2009, 46, 40-48.
38. Capeau, J., Magre, J., Caron-Debarle, M., Lagathu, C. et al., Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr. Dev. 2010, 19, 1-20.
39. Perez-Perez, R., Ortega-Delgado, F. J., Garcia-Santos, E., Lopez, J. A. et al., Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J. Proteome Res. 2009, 8, 1682-1693.
40. Peinado, J. R., Jimenez-Gomez, Y., Pulido, M. R., Ortega-Bellido, M. et al., The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots. Proteomics 2010, 10, 3356-3366.
41. Wilkosz, S., Ireland, G., Khwaja, N., Walker, M. et al., A comparative study of the structure of human and murine greater omentum. Anat. Embryol. (Berlin) 2005, 209, 251-261.
42. Tang, X. H., Gudas, L. J., Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 2011, 6, 345-364.
43. Gudas, L. J., Wagner, J. A., Retinoids regulate stem cell differentiation. J. Cell. Physiol. 2011, 226, 322-330.
44. Duester, G., Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134, 921-931.
45. Bonet, M. L., Ribot, J., Felipe, F., Palou, A., Vitamin A and the regulation of fat reserves. Cell. Mol. Life Sci. 2003, 60, 1311-1321.
46. Wolf, G., Retinoic acid activation of peroxisome proliferation-activated receptor delta represses obesity and insulin resistance. Nutr. Rev. 2010, 68, 67-70.
47. Tamori, Y., Sakaue, H., Kasuga, M., RBP4, an unexpected adipokine. Nat. Med. 2006, 12, 30-31; discussion 31.
48. Ost, A., Danielsson, A., Liden, M., Eriksson, U. et al., Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J. 2007, 21, 3696-3704.
49. Kelly, K. R., Kashyap, S. R., O'Leary, V. B., Major, J. et al., Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity (Silver Spring) 2010, 18, 663-666.
50. Gesta, S., Bluher, M., Yamamoto, Y., Norris, A. W. et al., Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. USA 2006, 103, 6676-6681.
51. Marchitti, S. A., Brocker, C., Stagos, D., Vasiliou, V., Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 2008, 4, 697-720.
52. Adams, M., Montague, C. T., Prins, J. B., Holder, J. C. et al., Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 1997, 100, 3149-3153.
53. Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Thomou, T. et al., Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 2006, 55, 2571-2578.
54. Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., Noy, N., Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129, 723-733.
55. Chen, G., Wang, H., Miller, C. T., Thomas, D. G. et al., Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol. 2004, 202, 321-329.
56. Glatt, S. J., Everall, I. P., Kremen, W. S., Corbeil, J. et al., Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc. Natl. Acad. Sci. USA 2005, 102, 15533-15538.
57. Scortegagna, M., Martin, R. J., Kladney, R. D., Neumann, R. G., Arbeit, J. M., Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 2009, 69, 2638-2646.
58. Trayhurn, P., Wang, B., Wood, I. S., Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr. 2008, 100, 227-235.
59. Arrigo, A. P., The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv. Exp. Med. Biol. 2007, 594, 14-26.
60. Rayner, K., Chen, Y. X., Siebert, T., O'Brien, E. R., Heat shock protein 27: clue to understanding estrogen-mediated atheroprotection? Trends Cardiovasc. Med. 2010, 20, 54-58.
61. Boden, G., Duan, X., Homko, C., Molina, E. J. et al., Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008, 57, 2438-2444.
62. Joo, J. I., Oh, T. S., Kim, D. H., Choi, D. K. et al., Differential expression of adipose tissue proteins between obesity-susceptible and -resistant rats fed a high-fat diet. Proteomics 2011, 11, 1429-1448.
63. Schmid, G. M., Converset, V., Walter, N., Sennitt, M. V. et al., Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 2004, 4, 2270-2282.
64. Sarr, O., Louveau, I., Kalbe, C., Metges, C. C. et al., Prenatal exposure to maternal low or high protein diets induces modest changes in the adipose tissue proteome of newborn piglets. J. Anim. Sci. 2010, 88, 1626-1641.
65. Navet, R., Mathy, G., Douette, P., Dobson, R. L. et al., Mitoproteome plasticity of rat brown adipocytes in response to cold acclimation. J. Proteome Res. 2007, 6, 25-33.
66. Forner, F., Kumar, C., Luber, C. A., Fromme, T. et al., Proteome differences between brown and white fat mitochondria reveal specialized metabolic functions. Cell Metab. 2009, 10, 324-335.
67. Kruger, M., Kratchmarova, I., Blagoev, B., Tseng, Y. H. et al., Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. USA 2008, 105, 2451-2456.
68. Sanchez, J. C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice. Proteomics 2003, 3, 1500-1520.
69. Lanne, B., Dahllof, B., Lindahl, C., Ebefors, K. et al., PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents. J. Proteome Res. 2006, 5, 1850-1859.
70. Birner-Gruenberger, R., Susani-Etzerodt, H., Waldhuber, M., Riesenhuber, G. et al., The lipolytic proteome of mouse adipose tissue. Mol. Cell. Proteomics 2005, 4, 1710-1717.
71. Hansson, O., Strom, K., Guner, N., Wierup, N. et al., Inflammatory response in white adipose tissue in the non-obese hormone-sensitive lipase null mouse model. J. Proteome Res. 2006, 5, 1701-1710.
72. Sun, K., Kusminski, C. M., Scherer, P. E., Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121, 2094-2101.
73. -/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Mol. Cell. Proteomics 2011, 10, M111.008094.
74. Solomon, C. G., The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol. Metab. Clin. North Am. 1999, 28, 247-263.
75. Escobar-Morreale, H. F., Insenser, M., Corton, M., Millan, J. L., Peral, B., Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome. Proteomics Clin. Appl. 2008, 2, 444-455.
76. Peral, B., Camafeita, E., Fernandez-Real, J. M., Lopez, J. A., Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev. Proteomics 2009, 6, 353-361.
77. Younossi, Z. M., Baranova, A., Stepanova, M., Page, S. et al., Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. J. Proteome Res. 2010, 9, 3218-3224.
78. Lavatelli, F., Perlman, D. H., Spencer, B., Prokaeva, T. et al., Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol. Cell. Proteomics 2008, 7, 1570-1583.
79. Rosenow, A., Arrey, T. N., Bouwman, F. G., Noben, J. P. et al., Identification of novel human adipocyte secreted proteins by using SGBS cells. J. Proteome Res. 2010, 9, 5389-5401.
80. Barcelo-Batllori, S., Corominola, H., Claret, M., Canals, I. et al., Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics 2005, 5, 4927-4935.
81. Barcelo-Batllori, S., Kalko, S. G., Esteban, Y., Moreno, S. et al., Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol. Cell. Proteomics 2008, 7, 378-393.
82. Joo, J. I., Kim, D. H., Choi, J. W., Yun, J. W., Proteomic analysis for antiobesity potential of capsaicin on white adipose tissue in rats fed with a high fat diet. J. Proteome Res. 2010, 9, 2977-2987.
83. Napolitano, L., The differentiation of white adipose cells. An electron microscope study. J. Cell. Biol. 1963, 18, 663-679.
84. Rodbell, M., Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 1964, 239, 375-380.
85. Poznanski, W. J., Waheed, I., Van, R., Human fat cell precursors. Morphologic and metabolic differentiation in culture. Lab Invest. 1973, 29, 570-576.
86. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J. et al., Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7, 211-228.
87. Kheterpal, I., Ku, G., Coleman, L., Yu, G. et al., Proteome of human subcutaneous adipose tissue stromal vascular fraction cells versus mature adipocytes based on DIGE. J. Proteome Res. 2011, 10, 1519-1527.
88. Bouwman, F. G., Claessens, M., van Baak, M. A., Noben, J. P. et al., The physiologic effects of caloric restriction are reflected in the in vivo adipocyte-enriched proteome of overweight/obese subjects. J. Proteome Res. 2009, 8, 5532-5540.
89. Wilson, A., Butler, P. E., Seifalian, A. M., Adipose-derived stem cells for clinical applications: a review. Cell Prolif. 2011, 44, 86-98.
90. Casteilla, L., Dani, C., Adipose tissue-derived cells: From physiology to regenerative medicine. Diabetes Metab. 2006, 32, 393-401.
91. Bunnell, B. A., Flaat, M., Gagliardi, C., Patel, B., Ripoll, C., Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008, 45, 115-120.
92. DeLany, J. P., Floyd, Z. E., Zvonic, S., Smith, A. et al., Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by adipogenesis. Mol. Cell. Proteomics 2005, 4, 731-740.
93. Noel, D., Caton, D., Roche, S., Bony, C. et al., Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell Res. 2008, 314, 1575-1584.
94. Trottier, V., Marceau-Fortier, G., Germain, L., Vincent, C., Fradette, J., IFATS collection: Using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells 2008, 26, 2713-2723.
95. Jeong, J. A., Ko, K. M., Park, H. S., Lee, J. et al., Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis. Proteomics 2007, 7, 4181-4191.
96. Lee, H. K., Lee, B. H., Park, S. A., Kim, C. W., The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis. Proteomics 2006, 6, 1223-1229.
97. Zeyda, M., Farmer, D., Todoric, J., Aszmann, O. et al., Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. (Lond) 2007, 31, 1420-1428.
98. Shoelson, S. E., Lee, J., Goldfine, A. B., Inflammation and insulin resistance. J. Clin. Invest. 2006, 116, 1793-1801.
99. Rabe, K., Lehrke, M., Parhofer, K. G., Broedl, U. C., Adipokines and insulin resistance. Mol. Med. 2008, 14, 741-751.
100. Singla, P., Bardoloi, A., Parkash, A. A., Metabolic effects of obesity: a review. World J. Diabetes 2010, 1, 76-88.
101. Sauma, L., Franck, N., Paulsson, J. F., Westermark, G. T. et al., Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes. Diabetologia 2007, 50, 195-201.
102. Lieber, J. G., Evans, R. M., Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J. Cell Sci. 1996, 109, 3047-3058.
103. Franke, W. W., Hergt, M., Grund, C., Rearrangement of the vimentin cytoskeleton during adipose conversion: Formation of an intermediate filament cage around lipid globules. Cell 1987, 49, 131-141.
104. Kumar, N., Robidoux, J., Daniel, K. W., Guzman, G. et al., Requirement of vimentin filament assembly for beta3-adrenergic receptor activation of ERK MAP kinase and lipolysis. J. Biol. Chem. 2007, 282, 9244-9250.
105. Breitling, R., Robust signaling networks of the adipose secretome. Trends Endocrinol. Metab. 2009, 20, 1-7.
106. Alvarez-Llamas, G., Szalowska, E., de Vries, M. P., Weening, D. et al., Characterization of the human visceral adipose tissue secretome. Mol. Cell. Proteomics 2007, 6, 589-600.
107. Szalowska, E., van Hijum, S. A., Roelofsen, H., Hoek, A. et al., Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media. Biotechnol. Prog. 2007, 23, 217-224.
108. Roelofsen, H., Dijkstra, M., Weening, D., de Vries, M. P. et al., Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Mol. Cell. Proteomics 2009, 8, 316-324.
109. Zvonic, S., Lefevre, M., Kilroy, G., Floyd, Z. E. et al., Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol. Cell. Proteomics 2007, 6, 18-28.
110. Zhong, J., Krawczyk, S. A., Chaerkady, R., Huang, H. et al., Temporal profiling of the secretome during adipogenesis in humans. J. Proteome Res. 2010, 9, 5228-5238.
111. Kim, J., Choi, Y. S., Lim, S., Yea, K. et al., Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 2010, 10, 394-405.
112. Lee, M. J., Kim, J., Kim, M. Y., Bae, Y. S. et al., Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J. Proteome Res. 2010, 9, 1754-1762.
113. Chen, X., Cushman, S. W., Pannell, L. K., Hess, S., Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach. J. Proteome Res. 2005, 4, 570-577.
114. Hocking, S. L., Wu, L. E., Guilhaus, M., Chisholm, D. J., James, D. E., Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue-derived microvascular endothelial cells. Diabetes 2010, 59, 3008-3016.
115. Ibrahim, M. M., Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11, 11-18.
116. Claessens, M., Saris, W. H., Bouwman, F. G., Evelo, C. T. et al., Differential valine metabolism in adipose tissue of low and high fat-oxidizing obese subjects. Proteomics Clin. Appl. 2007, 1, 1306-1315.
117. Corton, M., Botella-Carretero, J. I., Lopez, J. A., Camafeita, E. et al., Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum. Reprod. 2008, 23, 651-661.
118. Roche, S., Delorme, B., Oostendorp, R. A., Barbet, R. et al., Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 2009, 9, 223-232.
119. Ahmed, M., Neville, M. J., Edelmann, M. J., Kessler, B. M., Karpe, F., Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring) 2009, 18, 27-34.
120. Schicher, M., Morak, M., Birner-Gruenberger, R., Kayer, H. et al., Functional proteomic analysis of lipases and esterases in cultured human adipocytes. J. Proteome Res. 2010, 9, 6334-6344.
121. Giusta, M. S., Andrade, H., Santos, A. V., Castanheira, P. et al., Proteomic analysis of human mesenchymal stromal cells derived from adipose tissue undergoing osteoblast differentiation. Cytotherapy 2010, 12, 478-490.
122. Xie, X., Yi, Z., Bowen, B., Wolf, C. et al., Characterization of the human adipocyte proteome and reproducibility of protein abundance by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. J. Proteome Res. 2010, 9, 4521-4534.
123. Kim, B. S., Kang, K. S., Kang, S. K., Soluble factors from ASCs effectively direct control of chondrogenic fate. Cell Prolif. 2010, 43, 249-261.
124. Tunaitis, V., Borutinskaite, V., Navakauskiene, R., Treigyte, G. et al., Effects of different sera on adipose tissue-derived mesenchymal stromal cells. J. Tissue Eng. Regen. Med. 2010, 5, 733-746.
125. Oswald, E. S., Brown, L. M., Bulinski, J. C., Hung, C. T., Label-free protein profiling of adipose-derived human stem cells under hyperosmotic treatment. J. Proteome Res. 2011, 10, 3050-3059.
126. Famulla, S., Lamers, D., Hartwig, S., Passlack, W. et al., Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int. J. Obes. (London) 2011, 35, 762-772.
127. Bluher, M., Wilson-Fritch, L., Leszyk, J., Laustsen, P. G. et al., Role of insulin action and cell size on protein expression patterns in adipocytes. J. Biol. Chem. 2004, 279, 31902-31909.
128. Gondret, F., Guitton, N., Guillerm-Regost, C., Louveau, I., Regional differences in porcine adipocytes isolated from skeletal muscle and adipose tissues as identified by a proteomic approach. J. Anim. Sci. 2008, 86, 2115-2125.
129. Chen, X., Hunt, D., Cushman, S. W., Hess, S., Proteomic characterization of thiazolidinedione regulation of obese adipose secretome in Zucker obese rats. Proteomics Clin. Appl. 2009, 3, 1099-1111.
130. Morak, M., Schmidinger, H., Krempl, P., Rechberger, G. et al., Differential activity-based gel electrophoresis for comparative analysis of lipolytic and esterolytic activities. J. Lipid Res. 2009, 50, 1281-1292.
131. de Roos, B., Rungapamestry, V., Ross, K., Rucklidge, G. et al., Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 2009, 9, 3244-3256.
132. Jiang, L., Wang, Q., Yu, Y., Zhao, F. et al., Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS One 2009, 4, e6884.
133. Mishra, A., Cheng, C. H., Lee, W. C., Tsai, L. L., Proteomic changes in the hypothalamus and retroperitoneal fat from male F344 rats subjected to repeated light-dark shifts. Proteomics 2009, 9, 4017-4028.
134. Kanshin, E., Wang, S., Ashmarina, L., Fedjaev, M. et al., The stoichiometry of protein phosphorylation in adipocyte lipid droplets: analysis by N-terminal isotope tagging and enzymatic dephosphorylation. Proteomics 2009, 9, 5067-5077.
135. Shen, W. J., Patel, S., Eriksson, J. E., Kraemer, F. B., Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis. J. Proteome Res. 2010, 9, 1786-1794.
136. Valle, A., Sastre-Serra, J., Roca, P., Oliver, J., Modulation of white adipose tissue proteome by aging and calorie restriction. Aging Cell 2010, 9, 882-894.
137. Xie, W. D., Wang, H., Zhang, J. F., Kung, H. F. et al., Proteomic profile of visceral adipose tissues between low-fat diet-fed obesity-resistant and obesity-prone C57BL/6 mice. Mol. Med. Rep. 2010, 3, 1047-1052.
138. Taga, H., Chilliard, Y., Meunier, B., Chambon, C. et al., Cellular and molecular large-scale features of fetal adipose tissue: is bovine perirenal adipose tissue brown? J. Cell. Physiol. 2011, doi: 10.1002/jcp.22893.